NASDAQ:CTRV - Nasdaq -
3.58
+0.02 (+0.56%)
The current stock price of CTRV is 3.58 null. In the past month the price decreased by -31.15%. In the past year, price decreased by -93.09%.
ContraVir Pharmaceuticals Inc. is a biopharmaceutical company. The company is involved in the discovery and development of antiviral therapies. ContraVir Pharmaceuticals Inc. is headquartered in Edison, New Jersey.
Contravir Pharmaceut
399 THORNALL STREET FIRST FLOOR
EDISON NJ 08837
CEO: Robert Foster
Phone: 732-902-4000
The current stock price of CTRV is 3.58 null. The price increased by 0.56% in the last trading session.
The exchange symbol of Contravir Pharmaceut is CTRV and it is listed on the Nasdaq exchange.
CTRV stock is listed on the Nasdaq exchange.
Contravir Pharmaceut (CTRV) has a market capitalization of 2.87M null. This makes CTRV a Nano Cap stock.
Contravir Pharmaceut (CTRV) has a resistance level at 4.5. Check the full technical report for a detailed analysis of CTRV support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CTRV does not pay a dividend.
Contravir Pharmaceut (CTRV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.39).
Over the last trailing twelve months CTRV reported a non-GAAP Earnings per Share(EPS) of -1.39. The EPS decreased by -120.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -59.63% | ||
ROE | -730.21% | ||
Debt/Equity | 0.84 |
ChartMill assigns a Buy % Consensus number of 60% to CTRV. The Buy consensus is the average rating of analysts ratings from 1 analysts.